Amneal director exercises 34,819 RSUs into shares
Amneal Pharmaceuticals director Jeffrey P. George reported routine equity compensation activity.
Rhea-AI Filing Summary
Amneal Pharmaceuticals director Jeffrey P. George reported routine equity compensation activity. On May 7, 2026, he exercised 34,819 restricted stock units, receiving the same number of Class A Common Stock shares and bringing his direct holdings to 344,614 shares.
These 34,819 restricted stock units were previously granted and each unit represented a right to receive one share of Class A Common Stock upon vesting. On May 6, 2026, he was also awarded 19,824 new restricted stock units, which will convert into Class A shares when they vest under the company’s standard vesting schedule tied to the annual meeting and one‑year anniversary of grant.
Positive
- None.
Negative
- None.
Insider Trade Summary
34,819 shares exercised/converted
Exercise
3 txns
Insider
George Jeffrey P.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 34,819 | $0.00 | $0.00 |
| Exercise | Class A Common Stock | 34,819 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Units | 19,824 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Units — 19,824 contracts (Direct);
Class A Common Stock — 344,614 shares (Direct)
Footnotes (3)
- F1. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- F2. On May 6, 2025, the reporting person was granted 34,819 restricted stock units vesting on May 7, 2026.
- F3. Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.
Key Figures
RSUs exercised: 34,819 units
Shares held after exercise: 344,614 shares
New RSU grant: 19,824 units
+2 more
5 metrics
RSUs exercised
34,819 units
Converted into Class A Common Stock on May 7, 2026
Shares held after exercise
344,614 shares
Class A Common Stock held directly after May 7, 2026 transaction
New RSU grant
19,824 units
Restricted Stock Units granted on May 6, 2026
Prior RSU grant
34,819 units
Granted on May 6, 2025, vesting on May 7, 2026
Exercise price per RSU
$0.00 per unit
Conversion of restricted stock units into Class A Common Stock
Key Terms
Restricted Stock Units, Class A Common Stock, contingent right, annual meeting of stockholders
4 terms
Restricted Stock Units financial
"The filing reports transactions in “Restricted Stock Units” tied to Class A Common Stock."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Class A Common Stock financial
"Each restricted stock unit converts into one share of the Issuer's Class A Common Stock."
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
contingent right financial
"Each restricted stock unit represents a contingent right to receive one share."
annual meeting of stockholders financial
"Restricted stock units vest around the issuer's first annual meeting of stockholders following the grant."
FAQ
What did Amneal Pharmaceuticals (AMRX) director Jeffrey P. George report on this Form 4?
He reported routine equity compensation activity. On May 7, 2026, he exercised 34,819 restricted stock units into Class A Common Stock and, on May 6, 2026, he received a new grant of 19,824 restricted stock units as part of his director compensation.
What restricted stock unit grants were disclosed for Amneal (AMRX) director Jeffrey P. George?
The filing shows a grant of 34,819 restricted stock units on May 6, 2025, which vested on May 7, 2026, and a separate grant of 19,824 restricted stock units on May 6, 2026. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock.
How do Amneal (AMRX) restricted stock units work for Jeffrey P. George?
Each Amneal restricted stock unit represents a contingent right to receive one Class A Common share upon vesting. The units vest on the later of the day immediately before the first annual shareholder meeting after grant and the day immediately following the first anniversary of the grant date.
Were there any open‑market buys or sells by Jeffrey P. George in this Amneal (AMRX) Form 4?
No open‑market buys or sells are reported. The Form 4 shows only a derivative exercise of 34,819 restricted stock units into Class A Common Stock and a new grant of 19,824 restricted stock units, both recorded as compensation-related acquisitions, not market trades.
What vesting terms apply to the Amneal (AMRX) restricted stock units reported in this filing?
The restricted stock units vest on the later of two dates: the day immediately preceding Amneal’s first annual meeting of stockholders following the grant date and the day immediately following the first anniversary of the grant date. Once vested, each unit converts into one Class A share.
AI-generated analysis. How Rhea-AI works. Not financial advice.
